Combination of ataxia telangiectasia and Rad3-related inhibition with ablative radiotherapy remodels the tumor microenvironment and enhances immunotherapy response in lung cancer
Abstract We investigated the combined effects of ataxia telangiectasia and Rad3-related (ATR) inhibition, ablative radiotherapy, and immune checkpoint inhibitor (ICI) therapy against lung cancer. ATR inhibitor was administered combined with ablative radiotherapy to assess its radiosensitizing effect...
Saved in:
Main Authors: | Jenny Ling-Yu Chen, Chun-Kai Pan, Li-Cheng Lin, Yu-Sen Huang, Tsung-Hsuan Huang, Shu-Jyuan Yang, Sung-Hsin Kuo, Yu-Li Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2024-11-01
|
Series: | Cancer Immunology, Immunotherapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s00262-024-03864-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bladder Wall Telangiectasia in a Patient with Ataxia-Telangiectasia and How to Manage?
by: Fatma Deniz Aygün, et al.
Published: (2015-01-01) -
Drug repurposing screen for the rare disease ataxia-telangiectasia
by: Namrata Jayanth, et al.
Published: (2025-01-01) -
Tumor volume changes after stereotactic, hypofractionated and conventional radiotherapy in paragangliomas of head and neck
by: Paweł J. Polanowski, et al.
Published: (2024-09-01) -
Y90 Radiation Segmentectomy versus Microwave Ablation for Hepatocellular Carcinoma in Locations Suboptimal for Percutaneous Ablation
by: Olivia Kola, et al.
Published: (2025-01-01) -
Theoretical modeling of RF ablation with internally cooled electrodes:Comparative study of different thermal boundary conditions at theelectrode-tissue interface
by: María J. Rivera, et al.
Published: (2009-05-01)